COVID-19 TESTING

Quality Laboratory Service is proud to offer the most advanced FDA-approved COVID-19 testing solutions on the market. We are performing high sensitivity/high specificity SARS-CoV-2 antibody testing, COVID-19 diagnostic testing, and we have created 3 comprehensive panels designed to give physicians a complete picture of this patients' health during these difficult times. In particular, our Quarantine Wellness Panel is unique to QLS, and offers doctors a snapshot of their patients' health, including the SARS-CoV-2 antibody test. Click on the following links to learn more about these testing options!

Should you have any questions, please do not hesitate to contact us at 718-646-5100.

Physician Referral is required for all insurance claims.

$50 for self-pay patients. Please call us for discount eligibility.

SARS-CoV-2 Quarantine Wellness Panel

HEAVY METALS

What are Heavy Metals?

Heavy metals, like arsenic, lead, mercury, and others,are all around us. They’re in the ground we walk on, in the water we drink, and in the products we use every day. But high levels of most heavy metals are potentially toxic.QLS offers a comprehensive heavy metals panel in-house that helps physicians screen patients for a variety of medical conditions. Click on the following link to learn more about the testing options available!

Should you have any questions, please do not hesitate to contact us at 718-646-5100.

Learn more

1866 PAN-ANCA™ Evaluation

Components

NAME	METHOD	REFERENCE RANGE	UNITS
ANCA Total Autoantibodies	IFA/IMAGE	< 1:20	FIU
ANCA Pattern	IFA	By Report
Myeloperoxidase Autoantibodies	EIA	< 9.0	U/mL
Proteinase-3 Autoantibodies	EIA	< 3.5	U/mL
Antinuclear Antibodies (ANA)	IFA/IMAGE	<7.5	IU/mL
ANA Pattern	IFA	By Report

Specimen Requirements

	TYPE	VOLUME	TEMPERATURE	INSTRUCTIONS
PRIMARY
1	Serum	3 (2) mL	Ambient - 48 Hour(s), Refrigerated - 7 Day(s), Frozen - 2 Month(s)

Clinical utility

Antineutrophil cytoplasmic autoantibodies (ANCA) are a serological marker associated with vasculitis, glomerulonephritis and inflammatory bowel disease. Specifically, ANCA have been found (at frequencies ranging from 70% to 90%) in patients with active Wegener's granulomatosis, microscopic polyarteritis nodosa, and idiopathic crescentic glomerulonephritis (with manifestations ranging from kidney-limited disease to extrarenal systemic disease, including pulmonary-renal syndromes). Glomerular lesions in patients with ANCA-associated systemic vasculitis or renal-limited disease are virtually identical. Less than 10% of patients with other renal diseases are ANCA positive. ANCA may be directly involved in the pathogenesis of the vascular injury that causes the clinical manifestations in ANCA-associated disease.

Reported: Same day

CPT Code: 86021x3, 86038

Notes: If the result for ANCA Total Antibodies is 1:20 or greater, ANCA IgG, IgM and IgA Autoantibodies (Test Code 1022) may be requested.